Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Targeted ransomware attacks grow 767%, India among top targets

by AIP Online Bureau | Apr 26, 2021 | Eco/Invest/Demography, Indian News, Risk Management, Technology

  New Delhi, The ransomware attacks on high-profile targets such as corporations, government agencies and municipal organisations globally increased by a whopping 767 per cent in one year (from 2019 to 2020), according to a new report. Targeted ransomware attacks...

India records over 3.52 lakh new COVID-19 cases, 2812 deaths

by AIP Online Bureau | Apr 25, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic

  New Delhi: Amidst the devastating second wave of the COVID-19 pandemic, India reported 3.52 lakh fresh coronavirus cases in the last 24 hours. This is the highest single-day spike registered since the onset of the pandemic. A total of 3,52,991 new COVID-19...

Union Health Secretary writes to states for systematic implementation of vaccination Phase III

by AIP Online Bureau | Apr 25, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic, Policy, Regulation

  New Delhi: Union Health Secretary Rajesh Bhushan on Sunday wrote to Additional Chief Secretaries, Principal Secretaries, and to the health department of all states and union territories about facilitating the systematic implementation of phase III of the...

Covid surge likely due to lack of antibodies in seropositive people: CSIR

by AIP Online Bureau | Apr 25, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic

  New Delhi: The recurrence of coronavirus outbreak in March could have been be due to lack of "meaningful antibodies" in seropositive people after a peak in September last year, suggests a survey by the Council for Scientific and Industrial Research...

Bharat Biotech seeks DCGI nod to extend shelf life of Covaxin: Report

by AIP Online Bureau | Apr 25, 2021 | Eco/Invest/Demography, Health, Indian News, Pandemic

  New Delhi; Bharat Biotech has written to the India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday. Covaxin, along with Covishield manufactured by...
« Older Entries
Next Entries »

Recent Posts

  • GIC Re pays Rs 1,445 crore of dividend to govt in FY24-25
  • Govt hikes fitness test fee for over 20-year-old motor vehicles
  • Cyber attacks,Economic Slow down,Business Interruption ranked as top Indian business risks: Aon
  • TRAI orders mandatory adoption of 1600-series numbers by banks and insurance firms
  • AI driving direct shifts in global insurance industry, says Swiss Re

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy